Pharmaceutical

Resolution scores $83m to develop macrophage cell therapies

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and fibrotic indications.

Oct 4, 2024 - 04:00
Resolution scores $83m to develop macrophage cell therapies
Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and fibrotic indications.
Read the original article

Tags:

Previous Article

A rational design approach to RNA-targeting to target large-scale screening

Next Article

Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UPFs fuelling ‘alarming rise of chronic diseases’ in india

UPFs fuelling ‘alarming rise of chronic diseases’ in india

Oct 30, 2024

FDA accepts review of Viatris and Mapi’s NDA filing for GA Depot

FDA accepts review of Viatris and Mapi’s NDA filing for...

Aug 8, 2023

Mammograms are less effective for women with dense breast tissue. Medical experts disagree on what to do about it

Mammograms are less effective for women with dense brea...

Jan 24, 2024